# Anthropic IPO Official Site: Roadshow and Q3'26

> What ipo.anthropic.com shows: Q3 $17.0B revenue, a $23.3B net loss mostly non-cash, official 18-19 Nov dates, and why Indian investors are not on the broker list.
- **Published**: 2026-11-12
- **Modified**: 2026-11-15
- **Category**: ipo
- **URL**: https://www.tldr.money/articles/ipo/anthropic-ipo-official-site-roadshow-q3-results

---

Anthropic is now running a public roadshow site at [ipo.anthropic.com](https://ipo.anthropic.com/us/). This page is a reading of what that site, its documents and its FAQ actually say, checked on **12 November 2026**, and what they mean for an Indian resident. It sits alongside the [S-1 breakdown](/articles/ipo/anthropic-ipo) and the [invest-from-India guide](/articles/ipo/how-to-invest-in-anthropic-ipo-from-india). The [IPO hub](/ipo) collects the rest of our IPO coverage.

**Last updated: 12 November 2026.** Figures below are from the official site and the IPO fact sheet hosted there, or from [S-1/A No. 2](https://www.sec.gov/Archives/edgar/data/2130357/000162828026072484/anthropicpbc-sx1ax2.htm) where we say so. Headline dollars on the site are often rounded.

<div data-callout="note" data-title="Pricing week (15 November update)">

Anthropic is expected to price on 18 November and start trading on 19 November, US Eastern time: that is early morning 19 November and 8:00 pm IST on 19 November in India. The range is still $70-$78; there is no official final price yet. See [Anthropic IPO pricing week: what to watch from India](/articles/ipo/anthropic-ipo-pricing-week-what-to-watch).

</div>

> **Educational content, not investment advice.** This page explains a US initial public offering using the company's SEC filings and official sources. tldr.money is not a SEBI-registered investment adviser or research analyst, and is not a US broker-dealer. Nothing here is a recommendation to apply for, buy, sell or hold any security. US-listed shares can lose money, including on the first day of trade. The registration statement had not yet become effective as of 12 November 2026, so the shares could not yet be sold. Read the [prospectus on EDGAR](https://www.sec.gov/Archives/edgar/data/2130357/000162828026072484/anthropicpbc-sx1ax2.htm) and the [official IPO site](https://ipo.anthropic.com/us/), and speak to a qualified adviser if you need personal advice.

<div data-callout="tldr">

- **Official timetable (expected):** roadshow from **10 November**, pricing **18 November**, first trade **19 November**, all in **EST**, and **subject to regulatory clearance**.
- **Q3'26 headlines:** **$17.0 billion** revenue, **15%** adjusted operating margin, **(3)%** GAAP operating margin, **$23.3 billion** net loss including a **$21.9 billion** non-cash charge.
- **Retail path on the site:** an **indication of interest** at one of **five US brokers**. Allocation is confirmed on day one. There is **no guarantee of any shares**.
- **For Indian residents:** those five brokers are not India-facing platforms, and India is still not a listed public-offer jurisdiction. After listing, [buying under LRS](/articles/ipo/how-to-invest-in-anthropic-ipo-from-india) is a separate question.
- **Unchanged offer terms:** the expected **$70-$78** range and **825 million** shares still come from the **10 November S-1/A**, not from the marketing homepage.

</div>

## What the official site is

The site is a single-page roadshow room, not a substitute for the registration statement. On 12 November 2026 the US page was organised as:

1. A [founders' letter](https://ipo.anthropic.com/documents/us/founders-letter.pdf).
2. An 11-chapter roadshow video.
3. Q3'26 financial highlights.
4. Customer stories, with downloadable case-study PDFs.
5. A "How to participate" row of brokerage platforms.
6. Documents and a FAQ, including a [preliminary prospectus](https://ipo.anthropic.com/documents/us/prospectus.pdf) and an [IPO fact sheet](https://ipo.anthropic.com/documents/us/factsheet.pdf).
7. A legal notice that the registration statement has not yet become effective.

The legal notice points investors to [SEC EDGAR](https://www.sec.gov) and names Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC as contacts for the US prospectus. The fact sheet also lists Citigroup Global Markets Inc. as a further prospectus request contact. Naming them is not a recommendation of any underwriter.

## The timetable is now on the company FAQ

Until this site went up, the 18-19 November dates were reported by [CNBC](https://www.cnbc.com/2026/11/10/anthropic-sets-price-range-of-70-to-78-in-upcoming-ipo.html) as coming from people familiar with the plans. The company's own FAQ now says the same window, still as an expectation:

- The roadshow started on **10 November (EST)**.
- Subject to regulatory clearance, the final IPO share price is **expected** to be set on **18 November (EST)**.
- Shares are **expected** to begin publicly trading on **19 November (EST)**, under the ticker **ANT**, as Class A common stock on Nasdaq.

<div data-viz="timeline" data-id="anthropic-ipo-timeline">S-1 filed 26 Oct 2026; Q3 figures added 2 Nov; price range and roadshow 10 Nov; official site expects pricing on 18 Nov and first trade on 19 Nov 2026 (EST), subject to regulatory clearance.</div>

That is a firmer source than a news leak. It is still not a confirmed exchange timetable. The S-1 uses 19 November 2026 in its RSU share-count math, which is consistent with the FAQ, and the registration statement still has to become effective before any sale.

The FAQ also says the final price will reflect regulatory clearance, investor demand and market conditions. It does not print the **$70-$78** range on the page we checked. That range, the **825 million** share count, the **$26 billion** Class N private placement and the greenshoe remain in [S-1/A No. 2](/articles/ipo/anthropic-ipo-price-band-date). We found no contradiction; the marketing site simply does not repeat those terms in the FAQ.

## Q3'26, as the official site headlines it

<div data-viz="stats" data-id="anthropic-official-q3-highlights">Official-site Q3'26 headlines: $17.0bn revenue, 15% adjusted operating margin, (3)% GAAP operating margin, $23.3bn net loss including a $21.9bn non-cash charge, more than 11,900 large customers, and about $81bn October run-rate revenue.</div>

The highlights section is labelled **Q3'26 Financial highlights**. In the company's wording, and with the site's own footnotes:

| Official-site headline | What it is | S-1 exact figure, where we have one |
| --- | --- | ---: |
| $17.0B revenue | Q3 2026 revenue, also described as more than 12x year on year | $16,956 million |
| >11,900 customers >= $100K TTM revenue | Distinct organisations with at least $100,000 of trailing-twelve-month revenue, as of 30 September 2026; also described as more than 12x year on year | "more than 11,900", same date |
| >4x compute efficiency gain since Q1'25 | Revenue divided by compute and infrastructure expense in Q3'26, divided by the same ratio in Q1'25 | Consistent with the S-1 quarterly table ($16,956m / $9,863m versus $376m / $944m) |
| 15% adjusted operating margin | Non-GAAP; the site points to the prospectus reconciliation | $2,463 million of adjusted operating income in the IPO fact-sheet appendix, which is 15% of $16,956 million |
| (3)% operating margin | GAAP operating margin | $567 million operating loss on $16,956 million of revenue |
| $23.3B net loss, including a $21.9B non-cash charge | The charge is a change in the fair value of convertible notes, derivative liabilities and SAFEs, which the site ties to a higher valuation | Net loss $23,291 million; fair-value charge $21,936 million |

None of those official headlines conflict with the S-1. They are rounded, and the adjusted-margin figure is the Q3 number; the S-1's **12%** adjusted operating margin is for the **first nine months** of 2026, not the third quarter alone. The [financials page](/articles/ipo/anthropic-ipo-financials-s1) keeps the exact filing figures.

<div data-viz="bars" data-id="anthropic-q3-net-loss-components">Q3 net loss is dominated by a $21.9bn non-cash fair-value charge; the remaining GAAP loss is much smaller.</div>

The useful distinction is the same one already in the S-1: almost all of the $23.3 billion GAAP loss is a mark on convertible notes and related instruments, not $23.3 billion of cash leaving the business in the quarter. It is still a GAAP loss. The operating line is a $567 million loss, or about **(3)%** of revenue, after a $974 million operating *profit* in Q2.

Two other official-site and fact-sheet points are easy to misread if they are flattened into the same sentence:

- **Compute efficiency** is headline **more than 4x** from Q1'25 to Q3'26. The fact sheet's own chart shows the ratio rising to **2.08x** in Q2'26 and then easing to **1.72x** in Q3, and it says Q3 improvements were "partially offset" by **$5.0 billion** of compute delivered under short-term commitments, which "currently costs significantly more" than comparable compute under multi-year commitments. The long-run gain and the sequential dip can both be true.
- **Customer growth** is headline **more than 12x** year on year for the $100,000-plus cohort. The fact sheet *also* says that cohort rose about **8x** from Q4'25 to Q3'26. Those are different windows. We are not treating 8x and 12x as interchangeable.

The fact sheet also states **about $81 billion** of **run-rate revenue as of October 2026**. That is not Q3 GAAP revenue annualised by multiplying $17.0 billion by four, which would be $68 billion, and it is not a full-year forecast. The appendix defines it as an operating metric: trailing 28-day consumption-based fees multiplied by 13, plus aggregate monthly subscription fees multiplied by 12, as of the measurement date. We are reporting the company's figure and its definition, not restating it as recognised revenue.

## Customer stories the site chose to show

The "Our customers" section, plus a fifth panel for Walmart, is roadshow proof, not an audited customer list. The metrics below are the company's, as published on the site on 12 November 2026. We have not independently verified them.

**Legora**, described as scaling an "agentic operating system for lawyers." The site cites Jacob Lauritzen, CTO, and reports 1,500+ law firms and in-house teams served; 4.3 non-billable hours recaptured per lawyer weekly in an independent study of 31 firms; 100% Claude Enterprise employee access; and 14x Claude Code growth, from about 50 seats to 700 company-wide.

**Eli Lilly and Company**, "bringing the most powerful tools in science to every team." The site cites Diogo Rau, executive vice president and chief information and digital officer, and reports 50,000+ employees with access to Claude Enterprise, a 5x expansion since rollout, and more than 85% of employees in key functions actively engaging with Claude.

**Rakuten**, "turning every employee into a builder." The site cites Yusuke Kaji, general manager, AI for Business, and reports 70+ business units using AI, 99.9% code accuracy on complex code modifications, 7+ hours of autonomous coding, and new-feature time to market shortened from 24 working days to 5.

**Salesforce**, "re-engineering how a global enterprise builds itself." The site cites Marc Benioff, chair and CEO, and reports a 151% increase in effective output per developer year over year; an 18x faster API migration (231 days of work in 13 days); 2x quarter-over-quarter productivity gains, with an estimated 8.1 million hours annualised; and 99% of Salesforce employees using Slackbot.

**Walmart**, "making shopping faster, easier, and more personal." The site cites Daniel Danker, EVP, AI Acceleration, Product & Design, and reports 110%+ quarter-over-quarter growth in Sparky weekly active users, about a 35% higher average order value on Sparky orders versus non-Sparky orders, and a 2x+ quarter-over-quarter increase in units sold via Sparky.

The roadshow video has 11 chapters: Introduction; Our opportunity and core advantages; Product and platform; Frontier and safety research; Bristol Myers Squibb; Approach to compute; Accenture; Enterprise strategy; AIG; Financial model; and Conclusion. Bristol Myers Squibb, Accenture and AIG appear as video chapters; they are not in the written customer-story panels, and the site does not attach the same metric lists to those three names on the page we checked.

## What "indication of interest" means, and why it usually does not help from India

<div data-viz="table" data-id="anthropic-official-brokers">Official participating brokers on 12 November 2026: Charles Schwab, E*TRADE, Fidelity, Robinhood and SoFi. None is an India-facing platform.</div>

A US IPO is not a SEBI book. You do not bid through UPI or ASBA. On the official site, retail participation works like this:

1. You need an **active account** at a **participating brokerage platform**.
2. You submit an **indication of interest** on that platform.
3. The platform tells you whether you are **eligible**.
4. If you receive shares, the platform **confirms the allocation on the first day of trading**, expected to be 19 November (EST).
5. There is **no guarantee** that you will receive all, or any, of the shares you ask for. The FAQ still says you should be ready to purchase all of the shares for which you apply.
6. Shares bought in the IPO, if allotted, are bought at the **offering price** expected to be set on 18 November (EST). Shares bought after trading begins are bought at the **prevailing market price**.

On 12 November 2026, the only platforms in that "How to participate" row were **Charles Schwab**, **E*TRADE**, **Fidelity**, **Robinhood** and **SoFi**, each linked to that firm's US IPO page. That is a company list, not our ranking, and it can change. We are not saying any of those firms will accept a given account.

**INDmoney, Vested, Appreciate, Interactive Brokers and the 2026 GIFT City Global Access platforms are not on that official list.** We have not independently verified that any of them is offering ANT IPO allocations to typical resident-Indian clients. If a platform later claims otherwise, get the eligibility rules in writing. An indication of interest on a US brokerage platform usually depends on that platform's own residency and account rules; it is not the same thing as remitting rupees under the Liberalised Remittance Scheme.

The prospectus still lists public-offer jurisdictions that do not include India, as already covered in the [invest-from-India guide](/articles/ipo/how-to-invest-in-anthropic-ipo-from-india). The fact sheet also describes a European retail public offering in certain EEA countries and Switzerland. That is also not an Indian route.

For most resident individuals, the realistic path, if you want the exposure at all, remains **buying ANT after it lists**, under LRS, with TCS, currency spread and Indian tax on foreign shares in the plan. That map is in the how-to guide, not here.

## What we checked, and what we did not invent

We re-fetched [https://ipo.anthropic.com/us/](https://ipo.anthropic.com/us/) on 12 November 2026, including the documents and FAQ sections, and read the IPO fact sheet hosted on the same site. We compared the headlines with [S-1/A No. 2, 10 November 2026](https://www.sec.gov/Archives/edgar/data/2130357/000162828026072484/anthropicpbc-sx1ax2.htm).

We did **not** find a new price range, a new share count, or a new implied valuation on the official homepage. Where the site rounds ($17.0 billion, $23.3 billion, $21.9 billion, about $900 billion of commitments, about $96 billion of cash), we have kept the S-1's more precise figures next to the headlines. Where a figure appears only in the fact sheet, notably the **~$81 billion** October run-rate, we have labelled it as a company operating metric and quoted the definition.

## Related reading

- [Pricing week: what to watch, in IST](/articles/ipo/anthropic-ipo-pricing-week-what-to-watch)
- [Anthropic IPO: S-1 breakdown](/articles/ipo/anthropic-ipo)
- [How to invest in the Anthropic IPO from India](/articles/ipo/how-to-invest-in-anthropic-ipo-from-india)
- [Official IPO site, roadshow and Q3 highlights](/articles/ipo/anthropic-ipo-official-site-roadshow-q3-results)
- [Price range, shares and timeline](/articles/ipo/anthropic-ipo-price-band-date)
- [S-1 financials](/articles/ipo/anthropic-ipo-financials-s1)
- [The US government dispute](/articles/ipo/anthropic-ipo-trump-administration-risk)
- [Should you invest?](/articles/ipo/should-you-invest-in-anthropic-ipo)
- [How to invest in US stocks from India (2026)](/articles/ipo/how-to-invest-in-us-stocks-from-india)
- [IPO guides](/ipo)

## Sources

- [Anthropic official IPO site (US)](https://ipo.anthropic.com/us/), checked 12 November 2026, including the Q3'26 highlights, customer stories, participating-broker list, documents and FAQ.
- [Anthropic IPO fact sheet](https://ipo.anthropic.com/documents/us/factsheet.pdf), hosted on the official site (PDF last-modified 10 November 2026 on the server we fetched), for the October run-rate definition, compute-efficiency note, and the Q3 adjusted-operating-income reconciliation.
- [Preliminary prospectus on the official site](https://ipo.anthropic.com/documents/us/prospectus.pdf) and [Founders' letter](https://ipo.anthropic.com/documents/us/founders-letter.pdf).
- [Anthropic, PBC, Amendment No. 2 to Form S-1, 10 November 2026](https://www.sec.gov/Archives/edgar/data/2130357/000162828026072484/anthropicpbc-sx1ax2.htm), for exact offer terms and Q3 line items.
- [Anthropic roadshow announcement, 10 November 2026](https://www.anthropic.com/news/roadshow-launch).
- [CNBC, 10 November 2026](https://www.cnbc.com/2026/11/10/anthropic-sets-price-range-of-70-to-78-in-upcoming-ipo.html), earlier secondary reporting of the 18-19 November window, now also stated in the company's own FAQ.
---
- [More ipo articles](https://www.tldr.money/articles/category/ipo)
- [All articles](https://www.tldr.money/articles)